Rob Treml has been elevated to Vice President, Commercial Analytics, Insights & Digital Strategy at Incyte, where he will serve as a member of the US Commercial Leadership Team across Oncology and Immunology. He previously served as Vice President of Sales, Immunology at Incyte, following a long career in commercial, sales, marketing and market access leadership. Before joining Incyte, he held leadership roles at Johnson & Johnson and AstraZeneca, building extensive experience across immunology, oncology, specialty care and rare disease.
By Super Admin
|
October
03, 2026